Compare WYETH LTD with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs STERLING BIOTECH - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD STERLING BIOTECH WYETH LTD/
STERLING BIOTECH
 
P/E (TTM) x 27.7 -0.4 - View Chart
P/BV x 5.3 0.0 37,544.3% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 WYETH LTD   STERLING BIOTECH
EQUITY SHARE DATA
    WYETH LTD
Mar-13
STERLING BIOTECH
Dec-13
WYETH LTD/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,04411 9,946.7%   
Low Rs8183 24,058.8%   
Sales per share (Unadj.) Rs298.626.8 1,113.8%  
Earnings per share (Unadj.) Rs57.2-15.0 -382.7%  
Cash flow per share (Unadj.) Rs58.4-5.5 -1,069.3%  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.554.9 454.6%  
Shares outstanding (eoy) m22.72267.87 8.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.10.3 1,203.0%   
Avg P/E ratio x16.3-0.5 -3,501.0%  
P/CF ratio (eoy) x15.9-1.3 -1,253.1%  
Price / Book Value ratio x3.70.1 2,947.6%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,1571,862 1,136.4%   
No. of employees `0000.51.4 36.3%   
Total wages/salary Rs m400547 73.2%   
Avg. sales/employee Rs Th13,787.45,303.3 260.0%   
Avg. wages/employee Rs Th813.0403.8 201.3%   
Avg. net profit/employee Rs Th2,643.3-2,959.0 -89.3%   
INCOME DATA
Net Sales Rs m6,7837,181 94.5%  
Other income Rs m35343 827.7%   
Total revenues Rs m7,1367,223 98.8%   
Gross profit Rs m1,617947 170.8%  
Depreciation Rs m272,543 1.0%   
Interest Rs m64,377 0.1%   
Profit before tax Rs m1,938-5,931 -32.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632-1,924 -32.9%   
Profit after tax Rs m1,301-4,007 -32.5%  
Gross profit margin %23.813.2 180.8%  
Effective tax rate %32.632.4 100.6%   
Net profit margin %19.2-55.8 -34.4%  
BALANCE SHEET DATA
Current assets Rs m6,98414,335 48.7%   
Current liabilities Rs m2,05649,809 4.1%   
Net working cap to sales %72.6-494.0 -14.7%  
Current ratio x3.40.3 1,180.4%  
Inventory Days Days99403 24.6%  
Debtors Days Days24171 14.0%  
Net fixed assets Rs m24455,432 0.4%   
Share capital Rs m227268 84.8%   
"Free" reserves Rs m5,44113,935 39.0%   
Net worth Rs m5,66814,701 38.6%   
Long term debt Rs m259,478 0.3%   
Total assets Rs m7,90173,988 10.7%  
Interest coverage x353.3-0.4 -99,539.7%   
Debt to equity ratio x00.6 0.7%  
Sales to assets ratio x0.90.1 884.6%   
Return on assets %16.50.5 3,300.0%  
Return on equity %22.9-27.3 -84.2%  
Return on capital %34.0-6.4 -529.8%  
Exports to sales %0.225.9 0.8%   
Imports to sales %36.30.2 21,391.8%   
Exports (fob) Rs m151,860 0.8%   
Imports (cif) Rs m2,46512 20,208.2%   
Fx inflow Rs m151,860 0.8%   
Fx outflow Rs m2,67725 10,756.1%   
Net fx Rs m-2,6621,835 -145.1%   
CASH FLOW
From Operations Rs m9231,719 53.7%  
From Investments Rs m317-3,148 -10.1%  
From Financial Activity Rs m-4811,426 -33.7%  
Net Cashflow Rs m759-3 -22,326.5%  

Share Holding

Indian Promoters % 0.0 33.9 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 0.0 -  
FIIs % 7.2 9.9 72.7%  
ADR/GDR % 0.0 16.9 -  
Free float % 30.4 39.3 77.4%  
Shareholders   21,978 21,482 102.3%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   VENUS REMEDIES  ORCHID PHARMA LTD  NOVARTIS  J.B.CHEMICALS  SHASUN PHARMA  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 186 Points Higher; Energy and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS